Dalmau J,Armangué T,Planagumà J,Radosevic M,Mannara F,Leypoldt F,et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurology. 2019; 18:1045-1057.
 Graus F,Titulaer MJ,Balu R,Benseler S,Bien CG,Cellucci T,et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurology. 2016; 15:391-404.
 Weinshenker BG,Wingerchuk DM. Neuromyelitis Spectrum Disorders. Mayo Clinic Proceedings. 2017; 92:663-679.
 Wingerchuk DM,Banwell B,Bennett JL,Cabre P,Carroll W,Chitnis T,et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015; 85:177-189.
 Dalmau J,Gleichman AJ,Hughes EG,Rossi JE,Peng X,Lai M,et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology. 2008; 7:1091-1098.
 Guasp M,Dalmau J. Encephalitis associated with antibodies against the NMDA receptor. Med icina Clinica (Barc). 2018; 151:71-79.
 Lekoubou A,Viaccoz A,Didelot A,Anastasi A,Marignier R,Ducray F,et al. Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features. European Journal of Neurology. 2012; 19:e16-17.
 Hou C,Wu W,Tian Y,Zhang Y,Zhu H,Zeng Y,et al. Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children. Mult Scler Relat Disord 2020; 42:102018.
 Taraschenko O,Zabad R. Overlapping demyelinating syndrome and anti-N-methyl-d-aspartate receptor encephalitis with seizures. Epilepsy & Behavior Case Reports. 2019; 12:100338.
 Fan S,Xu Y,Ren H,Guan H,Feng F,Gao X,et al. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Multiple Sclerosis and Related Disorders. 2018; 20:144-152.
 Sinani AA,Maawali SA,Alshekaili J,Kindi MA,Ramadhani KA,Khabouri JA,et al. Overlapping demyelinating syndrome (Neuromyelitis optica spectrum disorders NMOSD with anti-NMDA receptor encephalitis); A case report. Mult Scler Relat Disord. 2020; 42:102153.
 Tao S,Zhang Y,Ye H,Guo D. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review. Multiple Sclerosis and Related Disorders. 2019; 35:185-192.
 Huda S,Whittam D,Bhojak M,Chamberlain J,Noonan C,Jacob A. Neuromyelitis optica spectrum disorders. Clinical Medicine.2019; 19:169-176.
 Zhu MX,Lu C,Xia CM,Qiao ZW,Zhu DN. Simvastatin pretreatment protects cerebrum from neuronal injury by decreasing the expressions of phosphor-CaMK II and AQP4 in ischemic stroke rats. Journal of Molecular Neuroscience .2014; 54:591-601.